The nonpartisan scorekeeper’s new report reinforces longstanding concerns about the 340B drug discount program, including ...

Spending through the 340B Drug Pricing Program rose by 565% between 2010 and 2021, increasing from $6.6 billion to $43.9 billion, according to a report from the Congressional Budget Office. In 2021, ...

The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several ...

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

A recent Executive Order takes aim at drug pricing, with significant implications for the 340B Drug Pricing Program. The Trump administration recently issued an Executive Order directing federal ...

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...

Created in 1992, the 340B Drug Pricing Program is a U.S. federal government program intended to give safety net providers—those that organize and deliver a significant level of both healthcare and ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

A bill bolstering a federal drug discount program that conservative critics have warned is a backdoor effort to subsidize transgender treatments for minors passed in the Oklahoma Senate last week, as ...

AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B “rebate models.” ...